You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

NOREPINEPHRINE BITARTRATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for norepinephrine bitartrate and what is the scope of patent protection?

Norepinephrine bitartrate is the generic ingredient in five branded drugs marketed by Hospira, Amneal, Baxter Hlthcare Corp, Breckenridge, Caplin, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Meitheal, Metrics Pharm, Mylan Labs Ltd, Sandoz, Sun Pharm, Zydus Pharms, Inforlife, Long Grove Pharms, and Eastman Kodak, and is included in nineteen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Norepinephrine bitartrate has three patent family members in two countries.

There are five drug master file entries for norepinephrine bitartrate. Twenty-two suppliers are listed for this compound.

Summary for NOREPINEPHRINE BITARTRATE
Drug Prices for NOREPINEPHRINE BITARTRATE

See drug prices for NOREPINEPHRINE BITARTRATE

Recent Clinical Trials for NOREPINEPHRINE BITARTRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of AlbertaPhase 4
Tunis UniversityPhase 4
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/A

See all NOREPINEPHRINE BITARTRATE clinical trials

Pharmacology for NOREPINEPHRINE BITARTRATE
Drug ClassCatecholamine
Medical Subject Heading (MeSH) Categories for NOREPINEPHRINE BITARTRATE

US Patents and Regulatory Information for NOREPINEPHRINE BITARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 210839-001 Dec 17, 2018 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Long Grove Pharms NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 214628-003 Oct 6, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Long Grove Pharms NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 214628-003 Oct 6, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Metrics Pharm NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 040522-001 Sep 30, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Inforlife NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 215700-003 Sep 15, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Gland Pharma Ltd NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 214323-001 May 6, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Caplin NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 217575-001 Sep 15, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NOREPINEPHRINE BITARTRATE

Country Patent Number Title Estimated Expiration
Canada 3051467 COMPOSITIONS DE NOREPINEPHRINE ET PROCEDES ASSOCIES (NOREPINEPHRINE COMPOSITIONS AND METHODS THEREFOR) ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2020217079 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2018140894 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.